This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Feb 27;299(8):885-7.

doi: 10.1001/jama.299.8.885.

Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct

PMID: 18314425
DOI: 10.1001/jama.299.8.885

Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct

Mike Mitka. JAMA. 2008.

. 2008 Feb 27;299(8):885-7.

doi: 10.1001/jama.299.8.885.

Author

PMID: 18314425
DOI: 10.1001/jama.299.8.885

No abstract available

PubMed Disclaimer

Similar articles

Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
Mitka M. Mitka M. JAMA. 2009 Feb 25;301(8):813-5. doi: 10.1001/jama.2009.196. JAMA. 2009. PMID: 19244181 No abstract available.
A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.
Huang X, Chen DY. Huang X, et al. ChemMedChem. 2012 Nov;7(11):1882-94. doi: 10.1002/cmdc.201200287. Epub 2012 Aug 20. ChemMedChem. 2012. PMID: 22907901 Review.
In brief: Ezetimibe/simvastatin (Vytorin) in chronic kidney disease.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2012 Jan 9;54(1381):4. Med Lett Drugs Ther. 2012. PMID: 22233589 No abstract available.
Ezetimibe + simvastatin (Merck/Schering-Plough).
Flores NA. Flores NA. Curr Opin Investig Drugs. 2004 Sep;5(9):984-92. Curr Opin Investig Drugs. 2004. PMID: 15503655 Review.
The SHARP trial: lessons learnt; answers and more questions!
Turagam M, Velagapudi P. Turagam M, et al. Int J Cardiol. 2012 Apr 5;156(1):e6. doi: 10.1016/j.ijcard.2011.07.057. Epub 2011 Aug 16. Int J Cardiol. 2012. PMID: 21849215 No abstract available.

See all similar articles

Cited by

Low molecular weight galactomannans-based standardized fenugreek seed extract ameliorates high-fat diet-induced obesity in mice via modulation of FASn, IL-6, leptin, and TRIP-Br2.
Kandhare AD, Bandyopadhyay D, Thakurdesai PA. Kandhare AD, et al. RSC Adv. 2018 Sep 18;8(57):32401-32416. doi: 10.1039/c8ra05204b. eCollection 2018 Sep 18. RSC Adv. 2018. PMID: 35547667 Free PMC article.
Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?
de Lorgeril M, Salen P, Defaye P, Rabaeus M. de Lorgeril M, et al. BMC Med. 2013 Jan 4;11:5. doi: 10.1186/1741-7015-11-5. BMC Med. 2013. PMID: 23289647 Free PMC article.
What are biomarkers?
Strimbu K, Tavel JA. Strimbu K, et al. Curr Opin HIV AIDS. 2010 Nov;5(6):463-6. doi: 10.1097/COH.0b013e32833ed177. Curr Opin HIV AIDS. 2010. PMID: 20978388 Free PMC article. Review.
Reporting bias in medical research - a narrative review.
McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. McGauran N, et al. Trials. 2010 Apr 13;11:37. doi: 10.1186/1745-6215-11-37. Trials. 2010. PMID: 20388211 Free PMC article. Review.
Bias, spin, and misreporting: time for full access to trial protocols and results.
Chan AW. Chan AW. PLoS Med. 2008 Nov 25;5(11):e230. doi: 10.1371/journal.pmed.0050230. PLoS Med. 2008. PMID: 19067481 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information